Cargando…
Triple Reuptake Inhibitors: A Premise and Promise
On the horizon there is a new class of psychoactive medications which work by inhibiting the neuronal reuptake of serotonin, norepinephrine, and dopamine. There are multiple potential indications for these drugs. Research suggests that they may have a role in treating depressive disorders, and it is...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Korean Neuropsychiatric Association
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2796030/ https://www.ncbi.nlm.nih.gov/pubmed/20046357 http://dx.doi.org/10.4306/pi.2008.5.3.142 |